Are transfectant cells essential for measuring cytotoxic T cells in paraneoplastic cerebellar degeneration? [5]

Annals of Neurology

Volumn 49, Issue 5, 2001, Pages 686-687

  Tanaka, Masami ^a   Tanaka, Keiko ^b  

^a Natl West Niigata Central Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; HLA ANTIGEN; RECOMBINANT PROTEIN;

ALLELE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; LETTER; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL;

HUMANS; PARANEOPLASTIC CEREBELLAR DEGENERATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0035023520     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1045     Document Type: Letter

References (9)

1. Darnell RB, Albert ML. cdr2-specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed. Ann Neurol 2000;48:270.
2. Tanaka M, Tanaka K, Idezuka J, Tsuji S. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. Exp Neurol 1998;150:337-338.
3. Tanaka M, Tanaka K, Shinozawa K, et al. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 1998; 161:88-90.
4. Brossart P, Bevan MJ. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 1997;90:1594-1599.
5. Tanaka M, Tanaka K. HLA A24 in paraneoplastic cerebellar degeneration with anti-Yo antibody. Neurology 1996;47:606-607.
6. Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999;50:201-212.
7. Davenport MP, Hill AVS. Reverse immunogenetics: from HLA-disease associations to vaccine candidates. Mol Med Today 1996; 2:38-45.
8. Albert M, Darnell JC, Bender A, et al. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998;11: 1321-1324.
9. Tanaka M, Tanaka K, Kira J, et al. Cytotoxic T cell activity against the peptide "AYRARALEL" from the Yo protein in patients with either HLA A24 or A2 and paraneoplastic cerebellar degeneration. Neurology 2000;54(Suppl 3):A38.